US FDA Remote Assessments Need Clearer Closeout Process, More Transparency, Experts Argue

 
• By Sue Sutter
  
Frosted glass
The details about RRA frequency and purpose are opaque. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from FDLI